Dievini Hopp BioTech Holding GmbH & Co. KG

Overview

dievini Hopp BioTech Holding, established 2005, is the life-sciences investment vehicle of Dietmar Hopp, co-founder of SAP, led by Friedrich von Bohlen and Christof Hettich. Follows a patient-capital, anti-cyclical, board-involved investment style (distinct from typical VC), focused on oncology, CNS, cell-based therapies, and personalized medicine; by 2007 had invested ~EUR320M across 15 biotech companies, with cumulative deployment exceeding EUR1.4bn, including a long-standing position in CureVac.

Key Facts

Type

Single Family Office